Stryker (SYK) Cash from Investing Activities (2009 - 2026)

Stryker's (SYK) quarterly Cash from Investing Activities came in at -$185.0 million in Q1 2026, up 95.53% year-on-year from -$94.6 million in Q1 2025, and up 39.34% on a QoQ basis from -$305.0 million in Q4 2025.

Stryker (SYK) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Cash from Investing Activities data on file, last reported at -$185.0 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 95.53% year-over-year to -$185.0 million in Q1 2026; TTM through Mar 2026 was -$915.0 million, a 86.4% increase from a year earlier, with the FY2025 full-year figure at -$4.9 billion, down 62.2% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$185.0 million, up from -$305.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for SYK reached as high as $72.0 million in Q3 2022 and fell as low as -$4.1 billion in Q1 2025.
  • Historically, Cash from Investing Activities has averaged -$702.2 million across 5 years, with a median of -$185.0 million in 2026.
  • On a YoY basis, Cash from Investing Activities climbed as much as 129.15% in 2022 and fell as far as 2693.75% in 2022.
  • Year by year, Cash from Investing Activities stood at -$162.0 million in 2022, then rose by 6.17% to -$152.0 million in 2023, then plunged by 99.34% to -$303.0 million in 2024, then declined by 0.66% to -$305.0 million in 2025, then surged by 39.34% to -$185.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$185.0 million in Q1 2026, -$305.0 million in Q4 2025, and -$321.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Steris 21.47 Bn 21.03 Bn 697.10 Mn -217.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -185.00 Mn
Mar 31, 2026 -185.00 Mn
Dec 31, 2025 -305.00 Mn
Dec 31, 2025 -305.00 Mn
Sep 30, 2025 -321.00 Mn
Sep 30, 2025 -321.00 Mn
Jun 30, 2025 -104.00 Mn
Jun 30, 2025 -104.00 Mn
Mar 31, 2025 -4.14 Bn
Mar 31, 2025 -4.14 Bn
Dec 31, 2024 -303.00 Mn
Dec 31, 2024 -303.00 Mn
Sep 30, 2024 -2.17 Bn
Sep 30, 2024 -2.17 Bn
Jun 30, 2024 -117.00 Mn
Jun 30, 2024 -117.00 Mn
Mar 31, 2024 -408.00 Mn
Mar 31, 2024 -408.00 Mn
Dec 31, 2023 -152.00 Mn
Dec 31, 2023 -152.00 Mn